Money Concepts Capital Corp Bristol Myers Squibb CO Transaction History

Money Concepts Capital Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $563,384 - $667,127	8,227 Added 46.99%	25,735 $1.85 Million
Q3 2022 Oct 27, 2022	SELL	$0.13 - $76.84 $9 - $5,609	-73 Reduced 0.42%	17,508 $1.25 Million
Q2 2022 Jul 18, 2022	SELL	$72.62 - $79.98 $1.59 Million - $1.75 Million	-21,896 Reduced 55.47%	17,581 $1.35 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $1.91 Million - $2.29 Million	31,095 Added 370.97%	39,477 $2.88 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $52,181 - $60,831	973 Added 13.13%	8,382 $523,000
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $185,971 - $209,163	-3,134 Reduced 29.73%	7,409 $468,000
Q4 2020 May 17, 2021	BUY	$57.74 - $65.43 $608,752 - $689,828	10,543 New	10,543 $654,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Money Concepts Capital Corp with notifications on news.